Miri Paas-Rozner

A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4 ⁺ T cells

Miri Paas-Rozner, Michael Sela, Edna Mozes · Proceedings of the National Academy of Sciences · 2003 · 41 citations

Life Sciences, Immunology, Pharmacology +17

Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.

Einat Zisman, Yael Katz‐Levy, Molly Dayan et al. · Proceedings of the National Academy of Sciences · 1996 · 38 citations

Life Sciences, Immunology, Pharmacology +17

A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses

Yael Katz‐Levy, Miri Paas-Rozner, Susan Kirshner et al. · Proceedings of the National Academy of Sciences · 1997 · 36 citations

Life Sciences, Immunology, Pharmacology +15

Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice

Miri Paas-Rozner, Molly Dayan, Yoav Paas et al. · Proceedings of the National Academy of Sciences · 2000 · 34 citations

Life Sciences, Immunology, Pharmacology +17

The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes

Miri Paas-Rozner, Michael Sela, Edna Mozes · Proceedings of the National Academy of Sciences · 2001 · 32 citations · Full text

Life Sciences, Immunology, Pharmacology +17